Trials / Completed
CompletedNCT00153127
Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications
Comparison of Braintree PolyethyleneGlycol(PEG) Laxative and Placebo for Relief of Constipation From Constipating Medications
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to assess treatment responses comparing a newly FDA-approved PEG laxative versus placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | polyethyleneglycol3350 |
Timeline
- Start date
- 2001-11-01
- Primary completion
- 2004-09-01
- First posted
- 2005-09-12
- Last updated
- 2013-02-07
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00153127. Inclusion in this directory is not an endorsement.